Diasolve Investigation of Market Potential for a Novel Vasodilator and Delivery Device for use in Cardiac Stress Testing and Stenting

Diasolve 对用于心脏压力测试和支架置入的新型血管扩张剂和输送装置的市场潜力进行调查

• 批准号: 700016
• 金额: $ 3.17万
• 依托单位: DIASOLVE LIMITED
• 依托单位国家: 英国
• 项目类别: GRD Proof of Market
• 财政年份: 2011
• 资助国家: 英国
• 起止时间: 2011 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=700016
• 关键词: Diasolve; Investigation; Market; Potential; Novel

Diasolve investigated the market potential for a novel pharmaceutical vasodilator and an accompanying device which combines targeted drug delivery and intra-arterial pressure measurement. The results indicate that the products are expected to have a positive impact on cardiac stress testing, by reducing patient risk and improving diagnostic accuracy, and have the potential to become the new standard of care. A robust financial model was built during the project which has shown that there is a substantial commercial opportunity. An adjusted verion of the model has now been used to underpin an application to develop the device under the Stratified Medicine competition "Determining Patient Response".

Diasolve调查了一种新型药物血管扩张剂和一种结合了定向药物输送和动脉内压测量的伴随设备的市场潜力。结果表明，这些产品有望通过降低患者风险和提高诊断准确性，对心脏负荷测试产生积极影响，并有可能成为新的护理标准。在该项目期间建立了一个强大的财务模型，这表明存在着巨大的商业机会。该模型的一个调整后的版本现在已被用来支持一个应用程序，该应用程序将在分层医学竞赛“确定患者反应”下开发该设备。